Latest Gaucher's disease Stories
Former head of rare diseases at Genzyme brings a 20-year track record of delivering successful, innovative products to patients throughout the world PHILADELPHIA, Dec.
DALLAS, December 9, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Gaucher's Disease - Pipeline Review, H2 2014" market research report of 74 pages with an overview of
INCLINE VILLAGE, Nev., Nov.
HARRISBURG, Pa., Oct.
With expanded screening test, 50 percent of Ashkenazi Jewish individuals are expected to be identified as carriers of at least one of the 38 diseases New York,
LEXINGTON, Massachusetts, February 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the
What causes brain damage and inflammation in severe cases of Gaucher disease?
Scientists have identified the biological pathway that explains Gaucher disease (GD) patients' higher risk for developing Parkinson's disease (PD).